Displaying 25 - 35 of 35

Display:

12 24 48

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View

Displaying 25 - 35 of 35

Display:

12 24 48